Separation of anxiety and depressive disorders

doi:10.1136/bmj.327.7419.869-b

From trainee to consultant, BMJ Group offers doctors around the world tailored information, special events, learning resources and recruitment services at every step along their career path.

... by doctors, for doctors, for patients
We are open for entries!

Online learning

BMJ Learning

High-quality CME / CPD for doctors and other healthcare professionals. BMJ Learning features hundreds of accredited, peer-reviewed learning modules in text, video, and audio formats. Find out more

Courses and Qualifications

BMJ Masterclasses

BMJ Masterclasses, led by experts, help clinicians to use the latest evidence and recent guidelines in practice and meet their CPD/CME requirements. Find out more

Exam Preparation

The leading provider of online exam preparation, helping over 167,000 healthcare professionals to pass their exams. Find out more

onExamination

Search all BMJ comment articles:

From

Limit by

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

New tools will lead to more valid classification system

Michael B First, associate professor of clinical psychiatry (mbf2@columbia.edu),
Darrel A Regier, director, division of research

Columbia University, 1051 Riverside Drive, Unit 60, New York, NY 10032, USA
American Psychiatric Association, 1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209, USA

EDITOR—Shorter and Tyrer's comments about the implications of separating depressive and anxiety disorders in the American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders (DSM) are perplexing, but not enlightening.1

Implying that this separation is impeding the development of new antidepressants, the authors cite an inverse relation between the number of patented new drugs and …